Venous thromboembolism prophylaxis in acutely ill medical patients: Definite need for improvement

Journal of Internal Medicine

Volumn 257, Issue 4, 2005, Pages 352-357

  Chopard, Pierre ^a,j   Dorffler Melly J ^b   Hess, U ^c   Wuillemin, W A ^d   Hayoz, D ^e   Gallino, A ^f   Bachli, E B ^g   Canova, C R ^h   Isenegger, J ^b   Rubino, R ⁱ   Bounameaux, H ^a  

^a UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c KANTONSSPITAL   (Switzerland)

^d LUZERNER KANTONSSPITAL   (Switzerland)

^e LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^f REGIONAL HOSPITAL OF LUGANO   (Switzerland)

^g UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^h Angiologie Spitäler Chur   (Switzerland)

ⁱ Aventis Pharma   (Switzerland)

^j GENEVA UNIVERSITY HOSPITALS   (Switzerland)

more..

Author keywords

Audit of practice; Guidelines; Medical patients; Thromboprophylaxis

Indexed keywords

ANTICOAGULANT AGENT; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADOLESCENT; ADULT; AGED; ANTICOAGULATION; ARTICLE; CLINICAL PRACTICE; EVIDENCE BASED MEDICINE; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; SWITZERLAND; THROMBOSIS PREVENTION; VENOUS THROMBOEMBOLISM;

EID: 20144387870     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2005.01455.x     Document Type: Article

References (18)

1. Geerts WH, Heit JA, Clagett GP et al. Prevention of venous thromboembolism. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 338S-400.
2. Consensus Report. Prevention of venous thromboembolism: international consensus statement (guidelines according to scientific evidence). Int Angiol 1997; 16: 3-38.
3. Sandercock PAG, van den Belt AGM, Lindley RI, Slattery J. Antithrombotic therapy in acute ischaemic stroke: an overview of de completed randomised trials. J Neurol Neurosurg Psychiatry 199; 56: 17-25.
4. Belch JJ, Lowe GDO, Ward AG, Forbes CD, Prentice CR. Prevention of deep vein thrombosis in medical patients by low-dose heparin. Scott Med J 1981; 36: 115-7.
5. Cade JF. High risk of the critically ill for venous thromboembolism. Crit Care Med 1982; 10: 448-50.
6. Halkin H, Goldberg J, Modan M, Modan B. Reduction of mortality in general medical in-patients by low-dose heparin prophylaxis. Ann Intern Med 1982; 348: 205-6.
7. Dahan R, Houlbert D, Caulin C et al. Prevention of deep vein thrombosis in elderly medical in-patients by a low molecular weight heparin: a randomized double-bind trial. Haemostasis 1986; 16: 159-64.
8. Ibarra-Pérez C, Lau-Cortes E, Colmenero-Zubiate S et al. Prevalence and prevention of deep venous thrombosis of the lower extremities in high-risk pulmonary patients. Angiology 1988; 39: 505-13.
9. Bergmann JF, Caulin C. Heparin prophylaxis in bedridden patients. Lancet 1996; 348: 205-6.
10. Gärdlund B. Randomised, controlled trial of low-dose heparin for prevention of fatal pulmonary embolism in patient with infectious disease. Lancet 1996; 347: 1357-61.
11. Samama MM, Cohen AT, Darmon JY et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in medical patients with Enoxaparin Study Group. N Engl J Med 1999; 341: 793-800.
12. Anderson FA Jr, Wheeler HB, Goldberg RJ, Hosmer DW, Forcier A, Patwardhan NA. Physician practices in the prevention of venous thromboembolism. Ann Intern Med 1991; 115: 591-5.
13. Aujesky D, Guignard E, Pannatier A, Cornuz J. Pharmacological thromboembolic prophylaxis in a medical ward. J Gen Intern Med 2002; 17: 788-91.
14. Chmelik P, Chopard P, Bounameaux H. An evaluation of thromboembolism prophylaxis in acutely ill medical patients. Swiss Med Wkly 2002; 132: 513-6.
15. Rahim SA, Panju A, Pai M, Ginsberg J. Venous thromboembolism prophylaxis in medical inpatients: a retrospective chart review. Thromb Res 2003; 111: 215-9.
16. Fiessinger JN, Chatelier G. Effect of prescription and monitoring recommendations on prescription of low-molecular weight heparins. Presse Med 1996; 25: 1777-80.
17. Durieux P, Nizard R, Ravaud P et al. A clinical decision support system for prevention of venous thromboembolism: effect on physician behavior. JAMA 2000; 283: 2816-21.
18. Alikhan R, Cohen AT, Combe S et al. Risk factors for venous thromboembolism in hospitalised patients with acute medical illness: analysis of the MEDENOX study. Arch Intern Med 2004; 164: 963-8.